1
|
Sanches RB, Poli VFS, Fidalgo JPN, Andrade-Silva SG, Cerrone LA, Oyama LM, Dâmaso AR, Dos Santos RT, Caranti DA. The hyperleptinemia state can downregulate cardiorespiratory fitness and energy expenditure in obese women. Physiol Behav 2017; 184:34-38. [PMID: 29097194 DOI: 10.1016/j.physbeh.2017.10.029] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2017] [Revised: 10/29/2017] [Accepted: 10/29/2017] [Indexed: 01/04/2023]
Abstract
INTRODUCTION In general, in obese people a state of hyperleptinemia may impair both energy balance and the inflammatory process. However, it has not been fully investigated whether there is a relationship between hyperleptinemia and cardiorespiratory fitness (CRF) and resting energy expenditure (REE), in obese women. METHODS 83 obese women were enrolled in this cross-sectional study. Anthropometric measures, body composition, REE, CRF and serum concentration of leptin were measured. Pearson's correlation coefficient was performed to examine the relationship between circulating leptin level and other clinical variables. Multiple regression analysis was applied to determine predictors of REE and CRF. Effects were considered significant at p≤0.05. RESULTS The most important finding in the present study is that the hyperleptinemia state was inversely correlated with CRF (r=-0.382, p=0.001) and REE (r=-0.447, p<0.001). Moreover, a positive correlation with fat mass was confirmed (r=0.419, p<0.001). In addition, hyperleptinemia was an independent negative predictor of REE (r2=-2.649, p=0.010) and CRF (r2=-2.335, p=0.023). CONCLUSION Together our results may suggest a vicious cycle between the state of hyperleptinemia and a decrease in energy expenditure and cardiorespiratory fitness in obese women, which can impair whole body energy homeostasis. This information is important to contribute to clinical practices.
Collapse
Affiliation(s)
- Ricardo Badan Sanches
- Post Graduate Program of Interdisciplinary Health Sciences, Universidade Federal de São Paulo/UNIFESP, Brazil; Obesity Study Group, Universidade Federal de São Paulo/UNIFESP, Brazil.
| | - Vanessa Fadanelli Schoenardie Poli
- Post Graduate Program of Interdisciplinary Health Sciences, Universidade Federal de São Paulo/UNIFESP, Brazil; Obesity Study Group, Universidade Federal de São Paulo/UNIFESP, Brazil
| | - João Pedro Novo Fidalgo
- Post Graduate Program of Interdisciplinary Health Sciences, Universidade Federal de São Paulo/UNIFESP, Brazil; Obesity Study Group, Universidade Federal de São Paulo/UNIFESP, Brazil
| | - Stephan Garcia Andrade-Silva
- Post Graduate Program of Interdisciplinary Health Sciences, Universidade Federal de São Paulo/UNIFESP, Brazil; Obesity Study Group, Universidade Federal de São Paulo/UNIFESP, Brazil
| | - Leticia Andrade Cerrone
- Post Graduate Program of Interdisciplinary Health Sciences, Universidade Federal de São Paulo/UNIFESP, Brazil; Obesity Study Group, Universidade Federal de São Paulo/UNIFESP, Brazil
| | - Lila Missae Oyama
- Department of Physiology, Universidade Federal de São Paulo/UNIFESP, Brazil
| | - Ana Raimunda Dâmaso
- Post Graduate Program of Interdisciplinary Health Sciences, Universidade Federal de São Paulo/UNIFESP, Brazil; Obesity Study Group, Universidade Federal de São Paulo/UNIFESP, Brazil; Department of Biosciences, Universidade Federal de São Paulo/UNIFESP, Brazil
| | - Ronaldo Thomatieli Dos Santos
- Post Graduate Program of Interdisciplinary Health Sciences, Universidade Federal de São Paulo/UNIFESP, Brazil; Department of Biosciences, Universidade Federal de São Paulo/UNIFESP, Brazil
| | - Danielle Arisa Caranti
- Post Graduate Program of Interdisciplinary Health Sciences, Universidade Federal de São Paulo/UNIFESP, Brazil; Obesity Study Group, Universidade Federal de São Paulo/UNIFESP, Brazil; Department of Biosciences, Universidade Federal de São Paulo/UNIFESP, Brazil
| |
Collapse
|
2
|
Sommer C, Gulseth HL, Jenum AK, Sletner L, Thorsby PM, Birkeland KI. Soluble Leptin Receptor and Risk of Gestational Diabetes in a Multiethnic Population: A Prospective Cohort Study. J Clin Endocrinol Metab 2016; 101:4070-4075. [PMID: 27537771 DOI: 10.1210/jc.2016-2583] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
CONTEXT Soluble leptin receptor (sOb-R), a potential marker of leptin resistance, is inversely associated with risk of type 2 diabetes, independently of leptin concentrations. We have previously shown that ethnic difference in leptin concentration may partly explain the increased risk of gestational diabetes (GDM) in South Asians. OBJECTIVE Our objective was to investigate whether sOb-R concentrations are associated with risk of GDM, whether concentrations of sOb-R differ across ethnic groups, and whether ethnic differences in sOb-R explain the ethnic differences in GDM risk. DESIGN AND SETTING The STORK Groruddalen study; a prospective cohort study of pregnant women living in Oslo, Norway, between May 2008 and May 2010. PARTICIPANTS Of the total sample (n = 823), 680 (47.1% Europeans) had sOb-R measured in pregnancy week 15 and an oral glucose tolerance test performed in week 28. MAIN OUTCOME MEASURE GDM was diagnosed according to World Health Organization 2013 criteria. RESULTS sOb-R was inversely associated with GDM (odds ratio, 0.76 [95% confidence interval, 0.69-0.83] per ng/ml increase in sOb-R, P < .001) in crude analysis. The association was attenuated after adjustments for covariates and leptin (0.85 [0.77-0.95], P = .004). Compared to women with sOb-R higher than 5 ng/ml, the odds ratio of GDM was 0.29(0.11-0.78; P = .014) among women with sOb-R greater than 10 ng/ml and 0.59 (0.37-0.94; P = .026) among women with sOb-R 5-10 ng/ml, in adjusted analysis. sOb-R levels did not differ across ethnic groups, and sOb-R did not explain ethnic differences in GDM risk. CONCLUSIONS There was an independent, inverse association between sOb-R and GDM, with the lowest risk of GDM observed among higher sOb-R concentrations.
Collapse
Affiliation(s)
- Christine Sommer
- Department of Endocrinology, Morbid Obesity and Preventive Medicine (C.S., H.L.G., K.I.B.), Oslo University Hospital, Oslo, Norway; Department of Non-Communicable Diseases (H.L.G.), Norwegian Institute of Public Health, Oslo, Norway; Department of General Practice (A.K.J.), Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Child and Adolescents Medicine (L.S.), Akershus University Hospital, Lørenskog, Norway; Hormone Laboratory (P.M.T.), Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine (K.I.B.), Faculty of Medicine, University of Oslo, Oslo, Norway
| | - Hanne Løvdal Gulseth
- Department of Endocrinology, Morbid Obesity and Preventive Medicine (C.S., H.L.G., K.I.B.), Oslo University Hospital, Oslo, Norway; Department of Non-Communicable Diseases (H.L.G.), Norwegian Institute of Public Health, Oslo, Norway; Department of General Practice (A.K.J.), Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Child and Adolescents Medicine (L.S.), Akershus University Hospital, Lørenskog, Norway; Hormone Laboratory (P.M.T.), Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine (K.I.B.), Faculty of Medicine, University of Oslo, Oslo, Norway
| | - Anne Karen Jenum
- Department of Endocrinology, Morbid Obesity and Preventive Medicine (C.S., H.L.G., K.I.B.), Oslo University Hospital, Oslo, Norway; Department of Non-Communicable Diseases (H.L.G.), Norwegian Institute of Public Health, Oslo, Norway; Department of General Practice (A.K.J.), Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Child and Adolescents Medicine (L.S.), Akershus University Hospital, Lørenskog, Norway; Hormone Laboratory (P.M.T.), Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine (K.I.B.), Faculty of Medicine, University of Oslo, Oslo, Norway
| | - Line Sletner
- Department of Endocrinology, Morbid Obesity and Preventive Medicine (C.S., H.L.G., K.I.B.), Oslo University Hospital, Oslo, Norway; Department of Non-Communicable Diseases (H.L.G.), Norwegian Institute of Public Health, Oslo, Norway; Department of General Practice (A.K.J.), Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Child and Adolescents Medicine (L.S.), Akershus University Hospital, Lørenskog, Norway; Hormone Laboratory (P.M.T.), Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine (K.I.B.), Faculty of Medicine, University of Oslo, Oslo, Norway
| | - Per Medbøe Thorsby
- Department of Endocrinology, Morbid Obesity and Preventive Medicine (C.S., H.L.G., K.I.B.), Oslo University Hospital, Oslo, Norway; Department of Non-Communicable Diseases (H.L.G.), Norwegian Institute of Public Health, Oslo, Norway; Department of General Practice (A.K.J.), Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Child and Adolescents Medicine (L.S.), Akershus University Hospital, Lørenskog, Norway; Hormone Laboratory (P.M.T.), Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine (K.I.B.), Faculty of Medicine, University of Oslo, Oslo, Norway
| | - Kåre Inge Birkeland
- Department of Endocrinology, Morbid Obesity and Preventive Medicine (C.S., H.L.G., K.I.B.), Oslo University Hospital, Oslo, Norway; Department of Non-Communicable Diseases (H.L.G.), Norwegian Institute of Public Health, Oslo, Norway; Department of General Practice (A.K.J.), Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Child and Adolescents Medicine (L.S.), Akershus University Hospital, Lørenskog, Norway; Hormone Laboratory (P.M.T.), Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine (K.I.B.), Faculty of Medicine, University of Oslo, Oslo, Norway
| |
Collapse
|
6
|
Asferg C, Mogelvang R, Flyvbjerg A, Frystyk J, Jensen JS, Marott JL, Appleyard M, Jensen GB, Jeppesen J. Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study. Am J Hypertens 2010; 23:327-33. [PMID: 20019673 DOI: 10.1038/ajh.2009.244] [Citation(s) in RCA: 73] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
BACKGROUND Leptin and adiponectin are hormones secreted by adipose tissue, and both hormones are candidate intermediaries between adipose tissue and overweight-related diseases. So far, no prospective study has been published where the independent effects of these two hormones on the development of hypertension have been directly compared. The objective of this study was to investigate the relationships between plasma levels of leptin and adiponectin and new-onset hypertension in the Copenhagen City Heart Study (CCHS). METHODS In a prospective study design, we examined new-onset hypertension in 620 women and 300 men who were normotensive in the third CCHS examination, which was performed in 1991-1994. RESULTS Between the third and the fourth CCHS examination, which was performed in 2001-2003, 254 had developed hypertension, defined as systolic blood pressure (SBP) > or = 140 mm Hg, or diastolic blood pressure (DBP) > or = 90 mm Hg, or use of antihypertensive medication. Using logistic regression analysis, adjusting for age, sex, estimated glomerular filtration rate, triglycerides, high-density lipoprotein cholesterol (HDL-C), fibrinogen, and glucose, and with leptin and adiponectin included in the same model, leptin was significantly associated with new-onset hypertension with an odds ratio (95% confidence interval) of 1.28 (1.08-1.53; P < 0.005) for 1 s.d. higher level of log-transformed leptin, whereas adiponectin was not significantly associated with new-onset hypertension having an odds ratio of 1.02 (0.84-1.24; P = 0.83) for 1 s.d. higher level of log-transformed adiponectin. CONCLUSIONS In the CCHS, leptin, but not adiponectin, was a significant independent predictor of new-onset hypertension.
Collapse
|
7
|
Cannon JG, Sabatier MJ, Marinik EL, Schwark EH, Haddow S, Cortez-Cooper M, Bergeron MF, Sloan GJ, McCully KK. Femoral artery diameter and arteriogenic cytokines in healthy women. Vascul Pharmacol 2008; 50:104-9. [PMID: 19068240 DOI: 10.1016/j.vph.2008.11.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2008] [Revised: 10/30/2008] [Accepted: 11/14/2008] [Indexed: 11/25/2022]
Abstract
Animal studies have identified monocyte chemoattractive protein-1 (MCP-1) and vascular endothelial growth factor (VEGF) as critical mediators of arterial diameter enlargement in response to chronic increases in blood flow (arteriogenesis). Furthermore, cellular studies have shown that the shear stresses resulting from increased blood flow stimulate synthesis of MCP-1, which in turn stimulates synthesis of VEGF. The purpose of this study was to determine if these mechanisms are evident in healthy women. Resting femoral artery diameter and blood flow, lean leg mass, MCP-1 and VEGF concentrations, and aerobic capacity were measured in 34 healthy women along with plasma concentrations of lipids associated with cardiovascular disease risk. Femoral artery diameter was independently related to metabolically active (lean) leg mass (b=0.41, P=0.008) and aerobic capacity (b=0.45, P=0.004). Plasma MCP-1 correlated negatively with the ratio of femoral artery diameter to lean leg mass (b=-0.42, P=0.009) and positively with serum triglycerides (b=0.46, P=0.005). Plasma VEGF exhibited similar correlations and strongly correlated with MCP-1 (R=0.92, P<0.0001). The results indicate that circulating MCP-1 and VEGF concentrations are associated with both arteriogenic and atherogenic stimuli in healthy women.
Collapse
Affiliation(s)
- Joseph G Cannon
- Medical College of Georgia, Department of Biomedical and Radiological Technologies, Augusta, GA 30912, United States.
| | | | | | | | | | | | | | | | | |
Collapse
|